Company logo

BCYC - Bicycle Therapeutics plc

NASDAQ -> Healthcare -> Biotechnology
Cambridge, United Kingdom
Type: Equity

BCYC price evolution
BCYC
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Current assets
Cash $890.86 $961.36 $457 $526.42
Short term investments
Net receivables $57.98 $46.68 $39.06 $24.04
Inventory
Total current assets $966.19 $1028.26 $515.96 $561.87
Long term investments
Property, plant & equipment $20.61 $22.52 $24.81 $27.68
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $996.75 $1057.36 $547.14 $595.34
Current liabilities
Accounts payable $5.71 $7.45 $7.06 $13.05
Deferred revenue
Short long term debt $27.5 $4.97 $4.88
Total current liabilities $56.41 $69.61 $49.51 $69.54
Long term debt $8.5 $30.8 $30.7
Total noncurrent liabilities
Total debt
Total liabilities $165.71 $183.54 $191.1 $224.41
Shareholders' equity
Retained earnings -$628.94 -$578.14 -$538.32 -$511.76
Other shareholder equity -$3.19 -$1.09 -$0.78 -$1.3
Total shareholder equity $873.81 $356.05 $370.93
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $526.42 $339.15 $438.68 $135.99
Short term investments
Net receivables $24.04 $21.21 $11.91 $14.63
Inventory
Total current assets $561.87 $369.38 $458.56 $155.72
Long term investments
Property, plant & equipment $27.68 $32.77 $17.79 $3.61
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $595.34 $410.61 $479.79 $161.15
Current liabilities
Accounts payable $13.05 $6.47 $2.72 $1.36
Deferred revenue
Short long term debt $4.88 $3.12 $2.38
Total current liabilities $69.54 $53.34 $36.24 $23.13
Long term debt $30.7 $30.32 $29.87 $14.51
Total noncurrent liabilities
Total debt
Total liabilities $224.41 $139.83 $133.54 $65.69
Shareholders' equity
Retained earnings -$511.76 -$331.1 -$218.38 -$151.56
Other shareholder equity -$1.3 $0.39 -$3.39 -$3.19
Total shareholder equity $370.93 $270.78 $346.25 $95.46
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Jan 2024
Revenue
Total revenue $9.36 $19.53 $5.33
Cost of revenue $38.3
Gross Profit -$28.94 $19.53
Operating activities
Research & development $47.37 $34.86
Selling, general & administrative $17.71 $16.38
Total operating expenses $56.01 $51.25 $59.75
Operating income -$46.65 -$31.72
Income from continuing operations
EBIT
Income tax expense $0.12 -$0.35 $0.32
Interest expense -$0.82 -$0.82 $5.64
Net income
Net income -$39.81 -$26.56 -$49.1
Income (for common shares) -$39.81 -$26.56
(in millions $) 31 Dec 2023 31 Jan 2023 31 Jan 2022 31 Jan 2021
Revenue
Total revenue $26.98
Cost of revenue $156.5
Gross Profit -$129.52
Operating activities
Research & development $180.96
Selling, general & administrative $60.43
Total operating expenses $216.92
Operating income -$189.95
Income from continuing operations
EBIT
Income tax expense $1.46
Interest expense -$3.26
Net income
Net income -$180.66
Income (for common shares) -$180.66
(in millions $) 30 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income -$39.81 -$26.56 -$49.1
Operating activities
Depreciation $1.64 $1.66 $1.65
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$44.63 -$70.87 -$47.29
Investing activities
Capital expenditures -$0.42 -$0.01 -$0.05
Investments
Total cash flows from investing -$0.87 -$0.42 -$0.01 -$0.05
Financing activities
Dividends paid
Sale and purchase of stock $549.61 $1.87
Net borrowings
Total cash flows from financing $519.55 $549.61 $1.87 $0.39
Effect of exchange rate $1.09
Change in cash and equivalents $364.44 $504.37 -$69.43 -$45.66
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income -$180.66 -$112.72 -$66.82 -$51.01
Operating activities
Depreciation $6.55 $3.69 $1.41 $1.28
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations -$60.63 -$86.11 -$14.79 -$17.79
Investing activities
Capital expenditures -$18.99 -$2.03 -$1.2
Investments
Total cash flows from investing -$2.93 -$18.99 -$2.03 -$1.2
Financing activities
Dividends paid
Sale and purchase of stock $250.03 $6.69 $305.73 $48.42
Net borrowings $15 $15
Total cash flows from financing $250.03 $6.69 $320.73 $62.84
Effect of exchange rate -$1.21 $0.02
Change in cash and equivalents $187.82 -$99.53 $302.69 $43.87
Fundamentals
Market cap $1.01B
Enterprise value N/A
Shares outstanding 69.02M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share 12.91
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.60
Net debt/EBITDA N/A
Current ratio 17.13
Quick ratio N/A